Ischemic Stroke Associated with Anticardiolipin Antibodies
Stroke 18:1101-1106, Levine,S.R.,et al, 1987
Multiple Cerebral Infarctions & Dementia Associated with Anticardiolipin Antibodies
Stroke 18:1107-1112, Coull,B.M.,et al, 1987
Peripheral Neuropathy Associated with Monoclonal IgM Autoantibody
Ann Neurol 22:764-767, Steck,A.J.,et al, 1987
Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987
Minimal Thyroid Ophthalmopathy
Neurol 37:1803-1808, Spector,R.H.&Carlisle,J.A., 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
Serologic Studies in the Diagnosis & Management of Meningitis Due to Sporothrix Schenckii
NEJM 317:935-940, 957-9591987., Scott,E.N.,et al, 1987
Chronic Forms of Borrelia Burgdorferi Infection of the Nervous System
Neurol 37:1031-1034, Wokke,J.H.J.,et al, 1987
Unusual Manifestations of Nervous System Borrelia Burgdorferi Infection
Arch Neurol 44:781-783, Midgard,R.&Hofstad,H., 1987
Expression of Human Immunodeficiency Virus in Cerebrospinal Fluid of Children with Progressive Encephalopathy
Ann Neurol 21:397-401, Epstein,L.G.,et al, 1987
Endemic Tropical Spastic Paraparesis Associated with HTLV-I:A Clinical & Seroepidem Study of 25 Cases
Ann Neurol 21:123-130, Vernant,J.C.,et al, 1987
Chronic Progressive Myelopathy Associated with Elevated Antibodies to HTLV-I & Adult T-Cell Leukemialike Cells
Ann Neurol 21:117-121, Osame,M.,et al, 1987
Cerebrovascular Ischemia Associated with Lupus Anticoagulant
Stroke 18:257-263, Levine,S.R.&Welch,K.M.A., 1987
Cerebral Venous Thrombosis with Lupus Anticoagulants, Report of Two Cases
Stroke 18:801-804, Levine,S.R.,et al, 1987
Recurrent Stroke Associated with Thymoma & Anticardiolipin Antibodies
Arch Neurol 44:678-679, Levine,S.R.,et al, 1987
Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Treatment of Gilles de la Tourette's Syndrome:Experience in a Predominantly Adult Population
Neurol 37:1828-1833, Mesulam,M.M.&Peterson,R.C., 1987
Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987
Lyme Disease, A Neuro-Ophthalmologic View
J Clin Neuro-ophthalmol 7:185-190, MacDonald,A.B., 1987
Evaluation of Sera From Patients with Lyme Disease in the FTA-ABS Test for Syphilis
Sex Trans Dis 13:232-236, Hunter,E.G.,et al, 1986
Association of Lupuslike Anticoagulant & Nonvasculitic Cerebral Infarction
Arch Neurol 43:851-852, Tabachnik-Schor,N.F.&Lipton,S.A., 1986
Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986
Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986
Expressions of Human Immunodeficiency Virus Antigen (HIV-Ag) in Serum & CSF During Acute & Chronic Infection
Lancet 2:177-180, Goudsmit,J.,et al, 1986
Neurologic Abnormalities in Lyme Disease without Erythema Chronicum Migrans
Am J Med 81:73-78, Beik,L.,et al, 1986
Alcoholic Dementia:A Hypothesis
Lancet 1:1184-1186, Lishman,W.A., 1986
Recurrent Cerebral Infarctions in Two Brothers with Antiphospholipid Antibodies that Block Coagulation Reactions
Stroke 17:98-102, Jacobson,D.M.,et al, 1986
Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Cerebral Infarct, TIA, & Lupus Inhibitor
Neurol 36:1234-1237, Fisher,M.&McGehee,W., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Cysticercosis-Review of 230 Patients
Bull Clin Neurosci 50:76-101, McCormick.G.F., 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Relapsing Ophthalmoparesis-Sensory Neuropathy Syndrome
Neurol 35:595-596, Kaplan,J.G.,et al, 1985
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985
Neurosyphilis
Arch Neurol 42:606-613, Simon,R.P., 1985
Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985